ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716857 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716857; 2) Community: the network communities that were significantly associated with the response to NSC 716857; 3) Molecule: the relationships between components within communities and NSC 716857; 4) MDR: the compounds that were significantly associated with the NSC 716857.

NSC Compound Enrichment Correlation
NSC 744658 6-(p-toluenesulfonylaminoethyl)diquino-1,4-thiazine 0.0459335986102865 -0.21657871
NSC 74702 Benzamide, N-[4-(2-anthraquinonylamino)-1-anthraquinonyl]- (8CI) 0.0459335986102865 0.39742491
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.0459335986102865 0.43376373
NSC 763635 N-(benzo[d]thiazol-2-yl)-2-phenyl-7-(3,4,5-trimethoxyphenyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide 0.0459335986102865 0.0027195565
NSC 661420 2-Chloro-3-(1-(4-methyl)piperazino)naphthazarin 0.0474314077111082 0.66562039
NSC 671883 Null 0.0474314077111082 0.65407163
NSC 672120 Oxireno[9,10]cyclodeca[1,2-b]furan-6,9(7H,10aH)-dione, 1a,2,3,7a,8,10b-hexahydro-1a,5-dimethyl-8-methylene-, stereoisomer 0.0474314077111082 0.53690488
NSC 679092 Null 0.0474314077111082 -0.31332331
NSC 123491 L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) 0.048939380959983 0.09732475
NSC 19441 FDA 0283 0.048939380959983 0.25772225
Total:131  Current:127    [First] [Prev] [Next] [Last]